mINSPIRERS\_RCT aims to assess the magnitude of the effect of a mobile app for improving asthma control in adolescents and adults with persistent asthma, followed at primary and secondary care in Portugal.
INSPIRERS\_RCT is a pilot randomized, multicenter superiority clinical trial regarding the effect of a mobile app together with usual care (experimental group) in comparison to usual care alone (control group) in adolescents and adults with persistent asthma. The study includes two face-to-face visits (initial visit and at 3 months), and 3 telephone interviews (1 week, 1 month and 4 months), implemented in 32 primary (General Practice) and secondary care centers (Allergy, Pediatrics, Pulmonology) in Portugal.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
124
Patients in the experimental group, in addition to usual care, will be invited to use the InspirerMundi app for 4 months to support adherence to preventive inhaled medication and their asthma self-management. The purpose of the InspirerMundi app is to transform the adherence process into a positive experience through immediate and pleasant rewards. The InspirerMundi app integrates 3 main components: monitoring (symptoms, control, adherence), gaming and social/peer support. Participants will be able to include their action plan in the app. Within the action plan, the application can lead to changes in the medication effectively taken, which means that the therapeutic level can be adjusted according to the action plan. Participants in the experimental arm will be able to share with their physician, through the app, their medication adherence and asthma control data in the 3 months visit, and whenever patients wish during the study period.
Usual care will consist of pharmacological treatment and medical monitoring through routine medical visits.
Faculty of Medicine of the University of Porto
Porto, Portugal
Asthma control (CARAT)
Change from baseline in the proportion of patients with controlled asthma as assessed with the CARAT-Control of Allergic Rhinitis and Asthma Test at 3 months
Time frame: Baseline, 3 months
Asthma control (GINA)
Change in Asthma control assessed by the physician acording to GINA (Global initiative for asthma) guidelines
Time frame: Baseline, 3 months
Change in Number of asthma exacerbations in last 3 months
Worsening asthma events requiring unscheduled health care use (emergency department visit, hospitalization, and/or any medical assistance) or initiation/increase in systemic corticosteroids.
Time frame: Baseline, 3 months
Change in Absenteeism in the last 3 months
Number of days absent from the workplace/school
Time frame: Baseline, 3 months
Change in Treatment adherence (Test of the Adherence to Inhalers)
Assessed with Test of the Adherence to Inhalers
Time frame: Baseline, 3 months
Change in Beliefs about Medicines
Assessed with specific Beliefs about Medicines Questionnaire
Time frame: Baseline, 3 months
Change in Satisfaction with inhaler
Assessed through 4 visual analogue scales (VAS 0-100, higher number, higher satisfaction)
Time frame: 1 week, 4 months
Change in EuroQol-5 Dimensions (EQ-5D)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessed with EuroQol-5 Dimensions (EQ-5D). Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead) to 1 (the value of full health), with higher scores indicating higher health utility.
Time frame: Baseline, 3 months